T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 44, 2010, Pages 18939-18943

  Serwold, Thomas ^a   Hochedlinger, Konrad ^b   Swindle, John ^c   Hedgpeth, Joe ^c   Jaenisch, Rudolf ^d   Weissman, Irving L ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c Complegen Inc ^*  (United States)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e STANFORD CANCER INSTITUTE   (United States)

Author keywords

Induced pluripotent stem cells; Lymphoma; Notch; Receptor mediated leukemogenesis; T cell receptor

Indexed keywords

NOTCH1 RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; BONE MARROW CELL; CANCER GROWTH; CARCINOGENESIS; CONFERENCE PAPER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; THYMUS;

MUS;

EID: 78650506474     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1013230107     Document Type: Article

References (43)

1. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
2. Hochedlinger K, Jaenisch R (2002) Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415:1035-1038.
3. Stadtfeld M, Brennand K, Hochedlinger K (2008) Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18:890-894.
4. Kim JB, et al. (2009) Direct reprogramming of human neural stem cells by OCT4. Nature 461:649-653.
5. Aoi T, et al. (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699-702.
6. Serwold T, Hochedlinger K, Inlay MA, Jaenisch R, Weissman IL (2007) Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes. J Immunol 179:928-938.
7. Aifantis I, Raetz E, Buonamici S (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8:380-390.
8. O'Neil J, Look AT (2007) Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26:6838-6849.
9. Weng AP, et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271.
10. Bellavia D, et al. (2002) Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci USA 99:3788-3793.
11. Brabb T, Rubicz R, Mannikko V, Goverman J (1997) Separately expressed T cell receptor alpha and beta chain transgenes exert opposite effects on T cell differentiation and neoplastic transformation. Eur J Immunol 27:3039-3048.
12. Jacobs H, et al. (1996) Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain. Oncogene 12:2089-2099.
13. Wang B, et al. (1997) CD3-epsilon overexpressed in prothymocytes acts as an oncogene. Mol Med 3:72-81.
14. Humpherys D, et al. (2002) Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad Sci USA 99:12889-12894.
15. Mir B, Zaunbrecher G, Archer GS, Friend TH, Piedrahita JA (2005) Progeny of somatic cell nuclear transfer (SCNT) pig clones are phenotypically similar to non-cloned pigs. Cloning Stem Cells 7:119-125.
16. Shimozawa N, et al. (2002) Abnormalities in cloned mice are not transmitted to the progeny. Genesis 34:203-207.
17. Robey EA, Bluestone JA (2004) Notch signaling in lymphocyte development and function. Curr Opin Immunol 16:360-366.
18. Aster JC, Pear WS, Blacklow SC (2008) Notch signaling in leukemia. Annu Rev Pathol 3: 587-613.
19. Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423:435-439.
20. Clipstone NA, Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697.
21. Beals CR, Clipstone NA, Ho SN, Crabtree GR (1997) Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 11:824-834.
22. Truneh A, Albert F, Golstein P, Schmitt-Verhulst AM (1985) Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318-320.
23. van Oers NS (1999) T cell receptor-mediated signs and signals governing T cell development. Semin Immunol 11:227-237.
24. Isakov N, Altman A (2002) Protein kinase C(theta) in T cell activation. Annu Rev Immunol 20:761-794.
25. Medyouf H, et al. (2007) Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 13:736-741.
26. Ito C, et al. (1998) Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells. Blood 91:1001-1007.
27. Hadland BK, et al. (2001) Gamma-secretase inhibitors repress thymocyte development. Proc Natl Acad Sci USA 98:7487-7491.
28. Loh Y-H, et al. (2010) Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7:15-19.
29. Seki T, et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11-14.
30. Staerk J, et al. (2010) Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7:20-24.
31. Yang L, Baltimore D (2005) Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc Natl Acad Sci USA 102: 4518-4523.
32. Baird S, Raschke W, Weissman IL (1977) Evidence that MuLV-induced thymic lymphoma cells possess specific cell membrane binding sites for MuLV. Int J Cancer 19:403-413.
33. McGrath MS, Weissman IL (1979) AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses. Cell 17:65-75.
34. Weissman IL, McGrath MS, Tamura G (1985) The receptor-mediated leukemogenesis hypothesis: a model of retroviral oncogenesis by viral stimulation of cell-surface receptors. Leukemia, ed Il W (Springer, New York), pp 235-249.
35. Weissman IL, Baird S (1977) Oncornavirus Leukemogenesis as a model for selective neoplastic transformation. Life Sciences Research Report 7: Neoplastic Transformation: Mechanisms and consequences, ed Koprowski H (Dahlem Komferenzen, Berlin), pp 135-152.
36. Weissman I (2005) Stem cell research: paths to cancer therapies and regenerative medicine. JAMA 294:1359-1366.
37. McGrath M, Weissman IL (1978) A receptor-mediated model of viral leukemogenesis: Hyptothesis and experiments. Cold Spring Harbor Meeting on Hematopoietic Mechanisms (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY), pp 557-589.
38. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
39. O'Neill HC, McGrath MS, Allison JP, Weissman IL (1987) A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus. Cell 49:143-151.
40. McGrath MS, Tamura G, Weissman IL (1987) Receptor mediated leukemogenesis: murine leukemia virus interacts with BCL1 lymphoma cell surface IgM. J Mol Cell Immunol 3:227-242.
41. Weng WK, Levy S (2003) Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 44:1113-1120.
42. Li JP, D'Andrea AD, Lodish HF, Baltimore D (1990) Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762-764.
43. Allman D, et al. (2001) Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med 194:99-106.